4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-016984
Options or other derivatives
- Chief Technology Officer acquired 295,875 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2023-03-03 | Grant or award · Employee Stock Option (Right to Buy) | +178,062 | 178,062 | D | ||
| Yan Ming Chief Technology Officer | 2023-03-03 | Grant or award · Restricted Stock Units | +117,813 | 117,813 | D | ||
Loading xslF345X03/doc4.xml…